These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3060795)

  • 1. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
    Riou G; Barrois M; Sheng ZM; Duvillard P; Lhomme C
    Oncogene; 1988 Sep; 3(3):329-33. PubMed ID: 3060795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
    Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
    Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
    Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
    Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix].
    Riou G; Barrois M; Tordjman I; Dutronquay V; Orth G
    C R Acad Sci III; 1984; 299(14):575-80. PubMed ID: 6097348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma.
    Ogata N; Kamimura T; Asakura H
    Hepatology; 1991 Jan; 13(1):31-7. PubMed ID: 1846346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ras mutations in human leukemia and related disorders.
    Greenberger JS
    Int J Cell Cloning; 1989 Nov; 7(6):343-59. PubMed ID: 2681441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of activated ras oncogenes in human thyroid carcinomas.
    Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proto-oncogenes and prognosis in early carcinoma of the uterine cervix.
    Riou GF
    Cancer Surv; 1988; 7(3):441-56. PubMed ID: 2853996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of active ras oncogenes in human bladder cancers associated with schistosomiasis.
    Fujita J; Nakayama H; Onoue H; Rhim JS; el-Bolkainy MN; el-Aaser AA; Kitamura Y
    Jpn J Cancer Res; 1987 Sep; 78(9):915-20. PubMed ID: 3117747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
    Mitra AB; Murty VV; Pratap M; Sodhani P; Chaganti RS
    Cancer Res; 1994 Feb; 54(3):637-9. PubMed ID: 7905784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
    Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
    Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
    Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
    Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the Kirsten-ras proto-oncogene in human preleukaemia.
    Liu E; Hjelle B; Morgan R; Hecht F; Bishop JM
    Nature; 1987 Nov 12-18; 330(6144):186-8. PubMed ID: 3313061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on ras P21 expression and mutation at 12th codon of C-Ha-ras oncogene in squamous cell carcinoma of the larynx].
    Yang Q
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(4):209-12, 251. PubMed ID: 8167038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
    Weismanová E; Kalúz S; Skorvaga M
    Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of N-ras induced by ultraviolet irradiation in vitro.
    Van der Lubbe JL; Rosdorff HJ; Bos JL; Van der Eb AJ
    Oncogene Res; 1988; 3(1):9-20. PubMed ID: 3060800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.